← Leaderboards
Robert Diluccio
Cormedix, Inc.
$281,494
Attributed
$281,494
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $224.4K · FY2017–19$250K$187.5K$125K$62.5K$0
'17
'18
'19
Funding mix
By agency
NIH$281,494 · 1
By mechanism
R43$281,494 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Amino Acids”
- Alan James Bridge · European Molecular Biology Laboratory$8,787,716
- Ian R Lanza · Mayo Clinic Rochester$5,625,920
- Chitra Upadhyay · Icahn School Of Medicine At Mount Sinai$4,972,038
- Rui Kong · Emory University$4,675,382
- Ahmed Abdelfattah · Brown University$4,550,209
- Alon Herschhorn · University Of Minnesota$4,482,305
Research focus
Amino AcidsAntimicrobialAnti-Bacterial AgentsBacterial InfectionsBiocompatible MaterialsBuffersApligrafCaringCell ModelCellsCessation Of LifeClinically RelevantCrude ExtractsDermalDermatologicBurn InjuryDigestionDoseEnzymesExposure ToFamily SuidaeFda ApprovedFormaldehydeFormulation
Grant awards (2)
Development of a novel combination of anti-septic taurolidine encased in a digestible nanoparticle system for use as topical treatment at burn sites$57,116
R43 · FY2019 · GM · contact PI
Development of a novel combination of anti-septic taurolidine encased in a digestible nanoparticle system for use as topical treatment at burn sites$224,378
R43 · FY2017 · GM · contact PI